Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Defibrillators Market Size Forecast: How Big Could The Market Get By 2030?
The defibrillators market has demonstrated robust expansion in recent years. It is anticipated to grow from $10.99 billion in 2025 to $11.81 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. This historical growth can be attributed to the increasing prevalence of cardiovascular diseases, rising demand for emergency cardiac care equipment, growing adoption of automated external defibrillators, increasing healthcare infrastructure development, and rising awareness about sudden cardiac arrest management.
The defibrillators market is anticipated to experience substantial expansion in the coming years, with its size projected to reach $15.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.0%. This forecasted growth is primarily driven by factors such as the increasing adoption of connected defibrillator technologies, the rising demand for home-based cardiac care solutions, the growing integration of AI-based cardiac monitoring, expanding healthcare digitization initiatives, and a heightened focus on advanced portable cardiac devices. During this period, major trends are expected to include the accelerating development of advanced cardiac rhythm monitoring technologies, the wider embrace of portable and wearable defibrillation devices, the increasing incorporation of real-time patient monitoring capabilities, an enhanced focus on optimizing defibrillator battery efficiency and performance, and the growing demand for automated emergency cardiac care solutions.
Get A Free Sample Report With In-Depth Market Insights:
Defibrillators Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of cardiovascular ailments is anticipated to boost the expansion of the defibrillators market moving ahead. These conditions, affecting the heart and blood vessels, encompass issues like coronary artery disease, heart failure, arrhythmias, and stroke, continuing to be a primary global cause of death. The rise in cardiovascular disease cases stems from an aging population, resulting in an expanding demographic susceptible to heart conditions and strokes. Defibrillators play a crucial role in managing cardiovascular diseases by facilitating prompt treatment for sudden cardiac arrest and serious cardiac rhythm irregularities, thus enhancing survival rates and decreasing cardiovascular fatalities. For example, a report from the National Center for Biotechnology Information (NCBI), a segment of the US-based National Library of Medicine (NLM), indicated in August 2025 that cardiovascular disease prevalence is forecast to increase by 90.0% from 2025 to 2050. During the same period, crude mortality is projected to climb by 73.4% and crude disability-adjusted life years (DALYs) by 54.7%, with overall deaths anticipated to escalate from 20.5 million in 2025 to 35.6 million by 2050. Consequently, the escalating incidence of cardiovascular diseases is propelling the expansion of the defibrillators market.
Defibrillators Market Segment Outlook: Which Categories Are Growing Fastest?
The defibrillators market covered in this report is segmented –
1) By Product Type: Implantable Cardioverter Defibrillators, External Defibrillators, Wearable Cardioverter Defibrillators, Automated External Defibrillators
2) By Technology: Biphasic Waveform Technology, Monophasic Waveform Technology, Connected Or Smart Internet Of Things Systems
3) By Distribution Channel: Direct Sales, Retail And Electronic Commerce
4) By Application: Ventricular Tachycardia And Ventricular Fibrillation, Sudden Cardiac Arrest, Cardiac Resynchronization Therapy, Atrial Fibrillation, Bradycardia
5) By End User: Hospitals And Clinics, Pre Hospital Emergency Care, Public Access Market, Home Care Settings, Alternative Care Settings, Pre Hospital Care Systems
Subsegments:
1) By Implantable Cardioverter Defibrillators: Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, Single Chamber Implantable Cardioverter Defibrillators, Dual Chamber Implantable Cardioverter Defibrillators
2) By External Defibrillators: Manual External Defibrillators, Manual Automated External Defibrillators, Biphasic External Defibrillators
3) By Wearable Cardioverter Defibrillators: Wearable Cardioverter Defibrillator Vests, Wearable Cardiac Monitoring Defibrillator Systems, Portable Wearable Defibrillation Devices
4) By Automated External Defibrillators: Semi Automated External Defibrillators, Fully Automated External Defibrillators, Public Access Automated External Defibrillators, Professional Use Automated External Defibrillators
Defibrillators Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the defibrillators market are actively pursuing the development of advanced products, such as extravascular implantable cardioverter defibrillator (EV-ICD) systems, with the goals of improving arrhythmia management, reducing complications associated with procedures, and enhancing the overall quality of life for patients. Extravascular implantable cardioverter defibrillator systems are sophisticated cardiac rhythm management devices that deliver vital defibrillation and pacing therapies without requiring leads inside the heart or blood vessels, thereby mitigating the risks linked to transvenous lead implantation. For example, in March 2025, Medtronic plc, an Ireland-based medical technology company, introduced the Aurora EV-ICD MRI device and Epsila EV MRI Lead in Japan, designed for the treatment of life-threatening ventricular arrhythmias. This system features an innovative lead placement beneath the sternum, enabling extravascular implantation while providing antitachycardia pacing (ATP), temporary backup pacing for bradycardia, and up to 40 joules of defibrillation energy. Additionally, it offers MRI compatibility, a projected battery life of 11.7 years, and proprietary sensing algorithms created to minimize inappropriate shocks. This innovation highlights the increasing focus on less invasive defibrillation technologies that combine advanced therapeutic capabilities with enhanced patient safety and improved long-term clinical outcomes.
Defibrillators Market Leading Companies And Competitive Benchmarking
Major companies operating in the defibrillators market are Abbott Laboratories, Medtronic plc, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Biotronik SE & Co. KG, Nihon Kohden Corporation, MicroPort Scientific Corporation, Schiller AG, EDAN Instruments Inc., Comen Medical Instruments Co. Ltd., Biolight Meditech Co. Ltd., Shenzhen Biocare Bio-Medical Equipment Co. Ltd., Bexen Cardio S.L., AMI Italia S.p.A., Yuwell Medical Co. Ltd.
View The Full Defibrillators Market Report:
Defibrillators Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the defibrillators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the defibrillators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.